Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of AP707 in Healthy Volunteers
NCT05267769Phase 1Completed
- Start
- Mar 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of adezunap in chronic pain and neuropathic pain. Primary endpoints: Area Under the Curve of THC at 24 hours, Maximum Observed Drug Concentration of THC at 24 hours and 1 more. Started Mar 2022; status: completed.
02
Drugs
adezunap
03
Conditions
chronic painneuropathic pain
Beyond the preview
Go deeper on NCT05267769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05267769.